In June an independent advisory committee recommended the FDA not approve MDMA assisted therapy for PTSD. This came as a surprise to many working in and following the field of psychedelic assisted therapy. It also raised questions as to where the field is at and what challenges still exist.
To provide some context and perspective on this decision and some of the specific criticism raised during the hearing Henrik Jungaberle, a psychedelic and public health researcher in Berlin joined the show.
This is the only link you need to subscirbe and never miss an episode of Two Brad For You. Please do rate and review it really helps us out.
If you'd like to support the show with currency click here. We are grateful for that too. Finally, you can check out the website here.
Podden och tillhörande omslagsbild på den här sidan tillhör Bradley van Paridon. Innehållet i podden är skapat av Bradley van Paridon och inte av, eller tillsammans med, Poddtoppen.
